NCT01549613View on ClinicalTrials.gov

Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
CellulitisSkin Infections
Interventions
DRUG

Daptomycin

• Daptomycin will be given in a one-time dose of 4mg/kg in a one-time dose to be infused over 2 minutes at the initiation of patient therapy in the RDTC cellulitis protocol.

DRUG

Vancomycin

• Vancomycin will be given in a dose of 15mg/kg at baseline and again at 12 hours to be infused over 1 to 2 hours.

Trial Locations (1)

45267

University of Cincinnati, Dept. of Emergency Medicine, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT01549613 - Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections | Biotech Hunter | Biotech Hunter